Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilufar Partovi

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Therapeutic Drug Monitoring|May 21, 2005
Clinical pharmacokinetic monitoring of itraconazole is warranted in only a subset of patientsSusan S Buchkowsky, Nilufar Partovi, Mary H H Ensom
Therapeutic Drug Monitoring|January 30, 2004
Ganciclovir in solid organ transplant recipients: is there a role for clinical pharmacokinetic monitoring?Julie Cates Scott, Nilufar Partovi, Mary H H Ensom
Clinical Pharmacokinetics|July 21, 2005
Sirolimus: the evidence for clinical pharmacokinetic monitoringSunita Bond Stenton, Nilufar Partovi, Mary H H Ensom
The Annals of Pharmacotherapy|November 19, 2009
The utility of therapeutic drug monitoring for ribavirin in patients with chronic hepatitis C--a critical reviewAlice H W Chan, Nilufar Partovi, Mary H H Ensom
The Canadian Journal of Hospital Pharmacy|January 11, 2024
Prioritizing Quality over Quantity: Defining Optimal Pharmacist-to-Patient Ratios to Ensure Comprehensive Direct Patient Care in a Medical or Surgical UnitShazia Damji, Michael Legal, Karen Dahri, et al.
The Canadian Journal of Hospital Pharmacy|October 26, 2020
How Hospital Pharmacists Spend Their Time: A Work-Sampling StudyDaniel Wong, Andrea Feere, Vandad Yousefi, et al.
Pharmacotherapy|February 26, 2008
Iron overload disorders: treatment options for patients refractory to or intolerant of phlebotomyPenny Bring, Nilufar Partovi, Jo-Ann E Ford, et al.
The Annals of Pharmacotherapy|July 3, 2008
Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction?Stefanie Lam, Nilufar Partovi, Lillian S L Ting, et al.
The Canadian Journal of Hospital Pharmacy|September 28, 2023
Pathways to Developing Clinical Pharmacist Practitioners: Is There a Better Way Forward? (Path-CPP)Ravi Parmar, Michael Legal, Karen Dahri, et al.
The Canadian Journal of Hospital Pharmacy|January 11, 2019
Evaluation of Collaborative Medication Reviews for High-Risk Older AdultsWinnie W T Chan, Karen Dahri, Nilufar Partovi, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Therapeutic Drug Monitoring|May 21, 2005
Clinical pharmacokinetic monitoring of itraconazole is warranted in only a subset of patientsSusan S Buchkowsky, Nilufar Partovi, Mary H H Ensom
Therapeutic Drug Monitoring|January 30, 2004
Ganciclovir in solid organ transplant recipients: is there a role for clinical pharmacokinetic monitoring?Julie Cates Scott, Nilufar Partovi, Mary H H Ensom
Clinical Pharmacokinetics|July 21, 2005
Sirolimus: the evidence for clinical pharmacokinetic monitoringSunita Bond Stenton, Nilufar Partovi, Mary H H Ensom
The Annals of Pharmacotherapy|November 19, 2009
The utility of therapeutic drug monitoring for ribavirin in patients with chronic hepatitis C--a critical reviewAlice H W Chan, Nilufar Partovi, Mary H H Ensom
The Canadian Journal of Hospital Pharmacy|January 11, 2024
Prioritizing Quality over Quantity: Defining Optimal Pharmacist-to-Patient Ratios to Ensure Comprehensive Direct Patient Care in a Medical or Surgical UnitShazia Damji, Michael Legal, Karen Dahri, et al.
The Canadian Journal of Hospital Pharmacy|October 26, 2020
How Hospital Pharmacists Spend Their Time: A Work-Sampling StudyDaniel Wong, Andrea Feere, Vandad Yousefi, et al.
Pharmacotherapy|February 26, 2008
Iron overload disorders: treatment options for patients refractory to or intolerant of phlebotomyPenny Bring, Nilufar Partovi, Jo-Ann E Ford, et al.
The Annals of Pharmacotherapy|July 3, 2008
Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction?Stefanie Lam, Nilufar Partovi, Lillian S L Ting, et al.
The Canadian Journal of Hospital Pharmacy|September 28, 2023
Pathways to Developing Clinical Pharmacist Practitioners: Is There a Better Way Forward? (Path-CPP)Ravi Parmar, Michael Legal, Karen Dahri, et al.
The Canadian Journal of Hospital Pharmacy|January 11, 2019
Evaluation of Collaborative Medication Reviews for High-Risk Older AdultsWinnie W T Chan, Karen Dahri, Nilufar Partovi, et al.
Pageof 5